ALKS

Alkermes
ALKS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$4.92B
EV
$4.11B
Shares Outstanding
164.90M
Beta
0.43

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$39.93
P/E 2025E
16.76x
P/Revenue 2025E
3.55x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Alkermes plc

gainify
ALKS

Alkermes plc

ALKS

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial...

Sector

Healthcare

Industry

Biotechnology

CEO

Pops, Richard

Employees

1,800

IPO Date

1991-07-16

Headquarters

Connaught House, 1 Burlington Road, Dublin 4, Dublin, Co. Dublin, D04 C5Y6, Ireland

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.